Co-Founder, Chief Clinical Officer, Jackie Iversen RPh MS spoke today in London at the 14th Annual CB&CDx Europe conference. Revolutionizing anti-inflammatory drug delivery with precision medicine
We are thrilled to announce (and this hit the press today) our groundbreaking partnership with KVK-Tech, a renowned Chemicals Manufacturing and Controls (CMC) company, to
This week, our Co-Founder and Chief Clinical Officer, Jackie Iversen RPh MS attended a gathering of innovators, journalists, and thought leaders in New York City
Two weeks ago, we received our patent for Canada, increasing the total number of countries covered by our intellectual property for this asset to 22.
We want to send a big thank you to those who joined us at our investor event last Thursday. It’s always a pleasure to speak
We’re excited to share some exciting news from the JP Morgan Healthcare Conference. Amidst the industry’s largest and most insightful investment conference, which was a
As the winter solstice marks the end of one period and the beginning of another, it’s a fitting time for reflection at Sen-Jam Pharmaceutical. As
Last Thursday’s webinar was another fantastic and engaging discussion. The topic of “Precision Medicine: Changing the Course of Inflammation For Good” was explored by both
Just this week, our Co-Founder and Chief Clinical Officer, Jackie Iversen, engaged in a candid conversation on the emerging platform, Loosid. This dynamic dialogue took
It was hard not to walk away from the fifth annual Age-Related Disease Conference and not be completely inspired by the numerous innovations these healthspan
© 2020 Sen-Jam Pharmaceutical